TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Tempest Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.60−0.02 (-3.86%)
Close on Oct 19, 2026
- Market cap
- $9.14M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Tempest Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 20, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2026 | Oct 19, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 17, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2026 | Sep 15, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2026 | Aug 24, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Jul 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 17, 2026 | Jul 22, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 27, 2026 | Jul 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 23, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 23, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 22, 2026 | May 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2026 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 9, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 27, 2026 | Dec 31, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 24, 2025 | Nov 26, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 19, 2025 | Nov 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 12, 2025 | SEC EDGAR |